Company

Curative Biotechnology, Inc.

Headquarters: Boca Raton, FL, United States

CEO: Mr. I. Richard Garr Esq., J.D.

OTC: CUBT -3.45%

Market Cap

$15.7 Million

USD as of Jan. 1, 2024

Market Cap History

Curative Biotechnology, Inc. market capitalization over time

Evolution of Curative Biotechnology, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Curative Biotechnology, Inc.

Detailed Description

Curative Biotechnology, Inc., doing business as Connectyx, a development-stage biomedical company, focuses on novel treatments for rare diseases. The company focuses on therapies with potentially accelerated development paths as a result of the disease, the nature of the therapeutic itself, or the stage of clinical development. Its pipeline candidates include CURB906, an antibody-drug conjugate for targeting CD56 positive brain tumors; and IMT504, a novel immune therapy to treat rabies. The company has an agreement with Mid-Atlantic BioTherapeutics, Inc. to develop the COVID-19 vaccine. Curative Biotechnology, Inc. was founded in 1995 and is based in Boca Raton, Florida.

Top 1-year algo backtest: +287.69%

$10,000 in March 2023 would now be $38,769 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

Curative Biotechnology, Inc. has the following listings and related stock indices.


Stock: OTC: CUBT wb_incandescent

Details

Headquarters:

1825 NW Corporate Boulevard

Suite 110

Boca Raton, FL 33431

United States

Phone: 561 418 7725